Case Report Describes Buprenorphine Care for Kratom Use Disorder During Pregnancy

Why it matters

Pregnancy adds potential maternal and neonatal withdrawal risks, while clinicians have limited evidence to guide treatment of kratom use disorder.

The big picture

This case report addresses a gap in perinatal care. It adapts buprenorphine, an established medication for opioid use disorder in pregnancy, to a kratom-use-disorder case while highlighting the need for collaborative, individualized care.

Key findings

• Prolonged kratom use can lead to substance use disorder and maternal or infant withdrawal.\nOnly a small number of published cases describe buprenorphine for kratom use disorder during pregnancy.\nEffective dosing and patient concerns require individualized assessment.\nScreening and outcome-tracking tools for perinatal kratom exposure remain limited.

What they say

The authors describe the report as illustrating strategies for diagnosing and managing kratom use disorder in pregnancy, while noting that treatment evidence remains limited.

Bottom line

**This case adds practical, early evidence for treating perinatal kratom use disorder with collaborative buprenorphine care.**